Pay in 4 interest-free payments of $5.25 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Ethics declarations Conflict of interest The authors declare no competing interests
And even though discovering the molecule was hard enough, putting it into the clinical application was a monumental task for us
The company expects to make YCANTH available to patients and caregivers by September, Ted White, Verricas president and CEO, said in a statement
These measures help ensure that researchers receive a formulation with reproducible characteristics suitable for scientific investigation
This matters for two reasons
US$ 27.53
US$ 25.33
US$ 25.31
US$ 21.76
US$ 25.08
US$ 27.13
US$ 24.60
US$ 25.01
